Garth Virgin

Vifor Pharma (Switzerland) — Switzerland

Medicine · Health Sciences

11h-index896citations19works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Iron Metabolism and Disorders(7), Erythropoietin and Anemia Treatment(6), Poxvirus research and outbreaks(6), Hemoglobinopathies and Related Disorders(5), Immunotherapy and Immune Responses(4)

Publications19 total

Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial
Movement Disorders·2017· 65 citedOpen Access
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
PLoS ONE·2016· 80 citedOpen Access
Anemia and iron deficiency in gastrointestinal and liver conditions
World Journal of Gastroenterology·2016· 148 citedOpen Access
Single-dose ferric carboxymaltose for the treatment of restless legs syndrome in iron deficient non-anaemic patients - a randomized, placebo-controlled trial
2016
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
PLoS ONE·2015· 6 citedOpen Access
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis
PLoS ONE·2015· 113 citedOpen Access
A multi-centre, multinational clinical study to investigate the safety and effectiveness of intravenous infusions of VIT-45 (Ferinject) in patients with iron deficiency anaemia (IDA) caused by chronic inflammatory bowel disease (IBD) in comparison with oral iron capsules
http://isrctn.com/·2015
Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population
PLoS ONE·2015· 50 citedOpen Access
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
Open Forum Infectious Diseases·2015· 140 citedOpen Access
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice
Anemia·2015· 17 citedOpen Access
Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases
BMC Gastroenterology·2014· 65 citedOpen Access
Prävalenz, Verlauf und Management der Eisenmangelanämie bei Patienten mit Colitis ulcerosa: Erste Ergebnisse von 372 Patienten aus der MUKOSA-Studie
Zeitschrift für Gastroenterologie·2014
[Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies].
PubMed·2014· 16 cited
Wirksamkeit und Verträglichkeit einer intravenösen Eisentherapie bei geriatrischen Patienten mit Anämie
MMW - Fortschritte der Medizin·2014· 10 cited
An Etiologic Profile of Anemia in 405 Geriatric Patients
Anemia·2014· 49 citedOpen Access
Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
The Journal of Infectious Diseases·2012· 131 citedOpen Access
3000 POSTER DISCUSSION Effectiveness and Tolerability of Ferric Carboxymaltose in the Correction of Cancer – and Chemotherapy-associated Anaemia – a Multicenter Observational Study
European Journal of Cancer·2011· 5 cited
Clinical experience with ferric carboxymaltose as treatment of cancer-associated anemia.
Journal of Clinical Oncology·2011
P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN®-multiantigen vaccine: high responder rate and considerable breadth of immunological response
Retrovirology·2009· 1 citedOpen Access

Frequent Co-authors

Paul Chaplin(7), Jürgen M. Stein(6), Alfred von Krempelhuber(6), Nathaly Arndtz-Wiedemann(5), Thomas Meyer(4), Philip Young(4), Richard N. Greenberg(4), Darja Schmidt(4), Richard Nichols(4), Tabea Geisel(4), Roland M. Schaefer(4), Matthias Bach(4), Siegfried Röesch(3), Edgar T. Overton(2), Jack T. Stapleton(2), Ian Frank(2), Eva Wagner(2), Josef Weigl(2), Nicole Bädeker(2), Jens Vollmar(2)